Compumedics Limited (CMP.AX)
AUD 0.26
(0.0%)
AUD 0.26
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -269 Thousand AUD | 92.39% |
| 2023 | -3.53 Million AUD | -2679.56% |
| 2022 | 137 Thousand AUD | -65.58% |
| 2021 | 398 Thousand AUD | 152.65% |
| 2020 | -756 Thousand AUD | -114.14% |
| 2019 | 5.34 Million AUD | 44.78% |
| 2018 | 3.69 Million AUD | 160.51% |
| 2017 | 1.41 Million AUD | -55.84% |
| 2016 | 3.21 Million AUD | 19.55% |
| 2015 | 2.68 Million AUD | 69.68% |
| 2014 | 1.58 Million AUD | 282.37% |
| 2013 | -868 Thousand AUD | 70.81% |
| 2012 | -2.97 Million AUD | -126.85% |
| 2011 | -1.31 Million AUD | -441.41% |
| 2010 | 384 Thousand AUD | -86.68% |
| 2009 | 2.88 Million AUD | 526.52% |
| 2008 | 460 Thousand AUD | -69.29% |
| 2007 | 1.49 Million AUD | 165.33% |
| 2006 | -2.29 Million AUD | 41.63% |
| 2005 | -3.92 Million AUD | -287.59% |
| 2004 | 2.09 Million AUD | 110.29% |
| 2003 | -20.34 Million AUD | -959.95% |
| 2002 | -1.91 Million AUD | -62.28% |
| 2001 | -1.18 Million AUD | -902.24% |
| 2000 | -118 Thousand AUD | -105.98% |
| 1999 | 1.97 Million AUD | 1745.0% |
| 1998 | -120 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -1.04 Million AUD | 70.54% |
| 2024 Q2 | -99 Thousand AUD | 0.0% |
| 2024 Q4 | -942 Thousand AUD | 0.0% |
| 2023 Q2 | -8.6 Million AUD | 0.0% |
| 2023 Q4 | 3.5 Million AUD | 0.0% |
| 2023 FY | -3.53 Million AUD | -2679.56% |
| 2022 Q4 | 1.02 Million AUD | 0.0% |
| 2022 Q2 | -891 Thousand AUD | 0.0% |
| 2022 FY | 137 Thousand AUD | -65.58% |
| 2021 Q4 | -761 Thousand AUD | 0.0% |
| 2021 FY | 398 Thousand AUD | 152.65% |
| 2021 Q2 | 1.15 Million AUD | 0.0% |
| 2020 Q4 | -1.26 Million AUD | 0.0% |
| 2020 Q2 | 574 Thousand AUD | 0.0% |
| 2020 FY | -756 Thousand AUD | -114.14% |
| 2019 FY | 5.34 Million AUD | 44.78% |
| 2019 Q4 | 3.9 Million AUD | 0.0% |
| 2019 Q2 | 1.17 Million AUD | 0.0% |
| 2018 FY | 3.69 Million AUD | 160.51% |
| 2018 Q4 | 2.72 Million AUD | 0.0% |
| 2018 Q2 | 973 Thousand AUD | 0.0% |
| 2017 Q4 | 962 Thousand AUD | 0.0% |
| 2017 FY | 1.41 Million AUD | -55.84% |
| 2017 Q2 | 456 Thousand AUD | 0.0% |
| 2016 Q2 | 1.56 Million AUD | 0.0% |
| 2016 FY | 3.21 Million AUD | 19.55% |
| 2016 Q4 | 1.65 Million AUD | 0.0% |
| 2015 Q4 | 1.61 Million AUD | 0.0% |
| 2015 FY | 2.68 Million AUD | 69.68% |
| 2015 Q2 | 1.06 Million AUD | 0.0% |
| 2014 Q2 | 540 Thousand AUD | 0.0% |
| 2014 FY | 1.58 Million AUD | 282.37% |
| 2014 Q4 | 1.04 Million AUD | 0.0% |
| 2013 FY | -868 Thousand AUD | 70.81% |
| 2013 Q2 | -293 Thousand AUD | 0.0% |
| 2013 Q4 | -575 Thousand AUD | 0.0% |
| 2012 FY | -2.97 Million AUD | -126.85% |
| 2012 Q3 | -464.5 Thousand AUD | 0.0% |
| 2012 Q2 | -464.5 Thousand AUD | -421.91% |
| 2012 Q1 | -89 Thousand AUD | 0.0% |
| 2012 Q4 | -464.5 Thousand AUD | 0.0% |
| 2011 Q3 | -89 Thousand AUD | 0.0% |
| 2011 Q4 | -89 Thousand AUD | 0.0% |
| 2011 FY | -1.31 Million AUD | -441.41% |
| 2011 Q1 | 184 Thousand AUD | 0.0% |
| 2011 Q2 | -89 Thousand AUD | -148.37% |
| 2010 Q2 | 184 Thousand AUD | -77.6% |
| 2010 Q3 | 184 Thousand AUD | 0.0% |
| 2010 Q4 | 184 Thousand AUD | 0.0% |
| 2010 FY | 384 Thousand AUD | -86.68% |
| 2010 Q1 | 821.25 Thousand AUD | 0.0% |
| 2009 FY | 2.88 Million AUD | 526.52% |
| 2009 Q4 | 821.25 Thousand AUD | 0.0% |
| 2009 Q2 | 821.25 Thousand AUD | 224.6% |
| 2009 Q1 | 253 Thousand AUD | 0.0% |
| 2009 Q3 | 821.25 Thousand AUD | 0.0% |
| 2008 Q1 | 488.25 Thousand AUD | 0.0% |
| 2008 FY | 460 Thousand AUD | -69.29% |
| 2008 Q4 | 253 Thousand AUD | 0.0% |
| 2008 Q3 | 253 Thousand AUD | 0.0% |
| 2008 Q2 | 253 Thousand AUD | -48.18% |
| 2007 FY | 1.49 Million AUD | 165.33% |
| 2007 Q4 | 488.25 Thousand AUD | 0.0% |
| 2007 Q3 | 488.25 Thousand AUD | 0.0% |
| 2007 Q2 | 488.25 Thousand AUD | 244.88% |
| 2007 Q1 | -337 Thousand AUD | 0.0% |
| 2006 Q1 | -733 Thousand AUD | 0.0% |
| 2006 Q3 | -337 Thousand AUD | 0.0% |
| 2006 Q4 | -337 Thousand AUD | 0.0% |
| 2006 FY | -2.29 Million AUD | 41.63% |
| 2006 Q2 | -337 Thousand AUD | 54.02% |
| 2005 Q3 | -733 Thousand AUD | 0.0% |
| 2005 Q2 | -733 Thousand AUD | -214.79% |
| 2005 Q4 | -733 Thousand AUD | 0.0% |
| 2005 Q1 | 638.54 Thousand AUD | 0.0% |
| 2005 FY | -3.92 Million AUD | -287.59% |
| 2004 Q3 | 638.54 Thousand AUD | 0.0% |
| 2004 Q2 | 638.54 Thousand AUD | 112.91% |
| 2004 Q4 | 638.54 Thousand AUD | 0.0% |
| 2004 Q1 | -4.94 Million AUD | 0.0% |
| 2004 FY | 2.09 Million AUD | 110.29% |
| 2003 FY | -20.34 Million AUD | -959.95% |
| 2003 Q4 | -4.94 Million AUD | 0.0% |
| 2003 Q3 | -4.94 Million AUD | 0.0% |
| 2003 Q2 | -4.94 Million AUD | -43864.51% |
| 2003 Q1 | 11.3 Thousand AUD | 0.0% |
| 2002 Q3 | 11.3 Thousand AUD | 0.0% |
| 2002 Q4 | 11.3 Thousand AUD | 0.0% |
| 2002 FY | -1.91 Million AUD | -62.28% |
| 2002 Q1 | 4.07 Million AUD | 0.0% |
| 2002 Q2 | 11.3 Thousand AUD | -99.72% |
| 2001 Q2 | 4.07 Million AUD | 7746.48% |
| 2001 FY | -1.18 Million AUD | -902.24% |
| 2001 Q3 | 4.07 Million AUD | 0.0% |
| 2001 Q1 | -53.25 Thousand AUD | 0.0% |
| 2001 Q4 | 4.07 Million AUD | 0.0% |
| 2000 Q4 | -53.25 Thousand AUD | 0.0% |
| 2000 Q2 | -53.25 Thousand AUD | -106.68% |
| 2000 Q3 | -53.25 Thousand AUD | 0.0% |
| 2000 Q1 | 797.25 Thousand AUD | 0.0% |
| 2000 FY | -118 Thousand AUD | -105.98% |
| 1999 Q2 | 797.25 Thousand AUD | 55.49% |
| 1999 FY | 1.97 Million AUD | 1745.0% |
| 1999 Q4 | 797.25 Thousand AUD | 0.0% |
| 1999 Q1 | 512.75 Thousand AUD | 0.0% |
| 1999 Q3 | 797.25 Thousand AUD | 0.0% |
| 1998 FY | -120 Thousand AUD | 0.0% |
| 1998 Q2 | 512.75 Thousand AUD | 0.0% |
| 1998 Q3 | 512.75 Thousand AUD | 0.0% |
| 1998 Q4 | 512.75 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 99.038% |
| Adherium Limited | -11.98 Million AUD | 97.756% |
| Aroa Biosurgery Limited | -9.78 Million AUD | 97.252% |
| Atomo Diagnostics Limited | -4.36 Million AUD | 93.832% |
| Anteris Technologies Ltd | -66.63 Million AUD | 99.596% |
| Control Bionics Limited | -5.92 Million AUD | 95.463% |
| CardieX Limited | -4.63 Million AUD | 94.195% |
| Cochlear Limited | 521.5 Million AUD | 100.052% |
| CleanSpace Holdings Limited | -4.81 Million AUD | 94.412% |
| Cyclopharm Limited | -9.22 Million AUD | 97.084% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | 83.338% |
| Nova Eye Medical Limited | -3.79 Million AUD | 92.915% |
| HeraMED Limited | -6.42 Million AUD | 95.815% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 98.469% |
| ImpediMed Limited | -19.03 Million AUD | 98.587% |
| InhaleRx Limited | -1.38 Million AUD | 80.598% |
| LBT Innovations Limited | -4.74 Million AUD | 94.325% |
| Micro-X Limited | -13.02 Million AUD | 97.935% |
| Neurotech International Limited | -5.58 Million AUD | 95.183% |
| OncoSil Medical Limited | -11.98 Million AUD | 97.755% |
| PolyNovo Limited | 1.16 Million AUD | 123.13% |
| Respiri Limited | -7 Million AUD | 96.157% |
| SomnoMed Limited | -3.84 Million AUD | 92.997% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 98.387% |
| Uscom Limited | -2.4 Million AUD | 88.812% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | 95.405% |